Gabrielle Morgan, O Greg Deardorff, Raja Hussain, Alexandria Choate, Manfredo Flores Cruz, Roger W Sommi, Niels C Beck
{"title":"A Pilot Study Exploring the Impact of Pro Re Nata Medication Utilization on Aggression in Forensic Psychiatric Patients.","authors":"Gabrielle Morgan, O Greg Deardorff, Raja Hussain, Alexandria Choate, Manfredo Flores Cruz, Roger W Sommi, Niels C Beck","doi":"10.64719/pb.15427","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze patterns of pro re nata (PRN) medication utilization during the seven-day periods preceding and following aggressive incidents in a forensic setting, including both psychotropic and somatic agents, to identify trends in use surrounding aggression.</p><p><strong>Methods: </strong>This was a retrospective chart review at a long-term state forensic psychiatric facility. Patients housed on units associated with the New Outlook Program (NOP) within a six-month period who received PRN medications were included.</p><p><strong>Results: </strong>Out of 106 patients evaluated, 42 were included. The mean age for study participants was 37 years old, with 83% being male. Out of 322 aggressive incidents, the overall PRN utilization rate was higher than the baseline in 38.8% of events (N = 125). For the overall seven-day period preceding and following an aggressive incident, there was no significant difference between psychotropic and somatic PRNs (β = -0.16, p = 0.74), and neither type showed a meaningful deviation from baseline (Intercept = -0.25, p = 0.46). Additionally, there was no significant difference in PRN utilization when separately assessing the seven-day period preceding or following an aggressive incident.</p><p><strong>Conclusion: </strong>No consistent group-level trends in PRN utilization were identified in relation to aggression. However, some patient-level variation was observed post-incident, suggesting individualized patterns compared to group-level trends. These findings support the clinical value of monitoring individuals' PRN utilization patterns to inform treatment planning.</p>","PeriodicalId":94351,"journal":{"name":"Psychopharmacology bulletin","volume":"56 1","pages":"92-97"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12795281/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.64719/pb.15427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To analyze patterns of pro re nata (PRN) medication utilization during the seven-day periods preceding and following aggressive incidents in a forensic setting, including both psychotropic and somatic agents, to identify trends in use surrounding aggression.
Methods: This was a retrospective chart review at a long-term state forensic psychiatric facility. Patients housed on units associated with the New Outlook Program (NOP) within a six-month period who received PRN medications were included.
Results: Out of 106 patients evaluated, 42 were included. The mean age for study participants was 37 years old, with 83% being male. Out of 322 aggressive incidents, the overall PRN utilization rate was higher than the baseline in 38.8% of events (N = 125). For the overall seven-day period preceding and following an aggressive incident, there was no significant difference between psychotropic and somatic PRNs (β = -0.16, p = 0.74), and neither type showed a meaningful deviation from baseline (Intercept = -0.25, p = 0.46). Additionally, there was no significant difference in PRN utilization when separately assessing the seven-day period preceding or following an aggressive incident.
Conclusion: No consistent group-level trends in PRN utilization were identified in relation to aggression. However, some patient-level variation was observed post-incident, suggesting individualized patterns compared to group-level trends. These findings support the clinical value of monitoring individuals' PRN utilization patterns to inform treatment planning.